Clinical Trials Insight: 700032674
Latest Information Update: 17 Apr 2008
Price :
$35 *
At a glance
- Drugs Muromonab CD3 (Primary) ; Glucosylceramide
- Indications Multiple sclerosis
- Focus Therapeutic Use
- Sponsors Hadasit
- 17 Apr 2008 New trial record.